Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T27468 |
GSK2793660 HCl
GSK-2793660,GSK2793660,GSK 2793660 |
||
GSK2793660 is a irreversible covalent α,β-unsaturated amide based DPP1 inhibitor. | |||
T70381 |
GSK2793660 free base
|
||
GSK-2793660 is a cathepsin C inhibitor that may be useful in the treatment of cystic fibrosis, noncystic fibrosis bronchiectasis, ANCA-associated vasculitis and bronchiectasis. | |||
T11466 |
GSK-2793660
|
Others | Others |
GSK-2793660 是一种具有口服活性并且不可逆的组织蛋白酶 C (Cathepsin C;CTSC) 抑制剂。GSK-2793660 是一种生物活性肽,可用于支气管扩张的研究。 | |||
T70380 |
ZBH-1205
|
||
ZBH-1205 is a novel camptothecin derivative, revealing potent antitumor activities mainly through cell apoptosis pathway, being more effective than cpt-11 and sn38 at inhibiting topoismerase-1 |